(Q38209851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Mitchell K.p. Lai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Rosa M Tordera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Paul T. Francis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Mitchell K P Lai

2

1 reference

31 August 2017

1 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

729-736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24802806%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40265-014-0217-5

17 March 2020

exact match

0 references

cites work

Role of serotonin in Alzheimer's disease: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-HT(6) receptor and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Serotonin in affective control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Mechanisms of sleep-wake cycle modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

The role of medullary serotonin (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Modulatory role of serotonin on feeding behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Serotonin innervation of basal ganglia in monkeys and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Serotonin innervation of human basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Molecular, pharmacological and functional diversity of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Role of serotonin in memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Molecular imaging of the 5-HT(1A) receptor in relation to human cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Role of the serotonin 5-HT(2A) receptor in learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Functional, molecular and pharmacological advances in 5-HT7 receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Neurotransmitter changes in early- and late-onset Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

(11) C and (18) F PET radioligands for the serotonin transporter (SERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

NMDA‐induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5‐HT1A antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Acute lecozotan administration increases learning and memory in rats without affecting anxiety or behavioral depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Drug development for Alzheimer's disease: where are we now and where are we headed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Treatment of the agitation of late-life psychosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Metabolism of a serotonin-4 receptor partial agonist 4-{4-[4-tetrahydrofuran-3-yloxy)-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (TBPT): identification of an unusual pharmacologically active cyclized oxazolidine metab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-hydroxytryptamine subtype 6 receptor modulators: a patent survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Advances in the design of 5-HT6 receptor ligands with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

21 January 2018

Dimebon disappointment

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Development of proneurogenic, neuroprotective small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Citalopram for agitation in Alzheimer's disease: design and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Sertraline for the treatment of depression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0217-5

Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat.

21 January 2018

1 reference

12 December 2020

Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication

1 reference

12 December 2020

Serotonin and emotion, learning and memory

1 reference

12 December 2020

Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density.

1 reference

12 December 2020

5-HT6 receptors and Alzheimer's disease

1 reference

12 December 2020

Structure and function of the brain serotonin system

1 reference

12 December 2020